CD4 and graft versus host disease: Several murine studies have established the ability of CD4+ T cells to promote GVHD, for example through major histocompatibiltiy complex (MHC) II presentation of intestinal microbiome antigens or other non-hematopoietic recipient antigens to promote GVHD (138–142).